Related Experiment Video

Updated: Aug 21, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

[Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki]

Xiao-Yu Niu1, Zhi-Lan Peng, He Wang

  • 1Obstetrics and Gynecology Department, West China Second Hospital, Sichuan University, Chengdu, Sichuan 610 041, P.R. China.

AI Zheng = Aizheng = Chinese Journal of Cancer
|November 4, 2004
PubMed
Abstract

Insights

RNA interference (RNAi) effectively targets HPV16 E6 oncogenes in cervical cancer cells. This study demonstrates high efficiency and specific inhibition of HPV16 E6 gene expression in CaSki cells, offering a promising therapeutic strategy.

Area of Science:

  • Molecular biology
  • Oncology
  • Virology

Context:

  • Cervical cancer tumorigenesis is linked to HPV E6 and E7 oncogenes.
  • Previous inhibition methods like ribozymes and antisense oligonucleotides have limitations.
  • RNA interference (RNAi) presents a potential alternative for targeting HPV oncogenes.

Purpose:

  • To evaluate the specific inhibitory effect of RNA interference (RNAi) on the HPV16 E6 gene.
  • To assess the time-efficiency of RNAi in a cervical cancer cell line (CaSki).

Summary:

  • Small interfering RNA (siRNA) targeting HPV16 E6 was synthesized and transfected into CaSki cells with 81% efficiency.
  • Significant reduction in HPV16 E6 mRNA and protein levels was observed post-transfection, with peak inhibition at 2 days.
  • Increased apoptosis rates were noted, particularly at 5 days post-transfection, indicating RNAi's impact on cell viability.

Impact:

  • RNAi demonstrates specific and high efficiency in inhibiting HPV16 E6 gene expression in CaSki cells.
  • This finding supports RNAi as a viable therapeutic approach for HPV-associated cervical cancer.
  • Further research can explore optimizing RNAi delivery and efficacy for clinical applications.

More Related Videos

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter06:59

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter

Published on: March 31, 2022

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...